200
Participants
Start Date
July 31, 2007
Primary Completion Date
June 30, 2011
Study Completion Date
June 30, 2011
Chemotherapy (DAUNORUBICINE-CYTARABINE)
A Phase 3 Trial of Systematic versus Response-adapted Timed-SEQUENTIAL Induction in Patients with Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)
Chemotherapy (DAUNORUBICINE-CYTARABINE)
Chemotherapy induction sequential
Service Hematologie Oncologie, Nîmes
Acute Leukemia French Association
OTHER
French Innovative Leukemia Organisation
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER